United Orthopedic Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	11.4yrs

Actualizaciones recientes de la dirección

Recent updates

Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

Apr 26

United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

Apr 12

What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 08

Is United Orthopedic (GTSM:4129) A Risky Investment?

Feb 16

Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

Jan 29

Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Jan 11

Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Dec 24

How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 03

CEO

United Orthopedic no tiene CEO, o no tenemos datos al respecto.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Lin Terchien	President	less than a year	sin datos	sin datos
Yuan-Chang Deng	Divisional Head of Department of Finance & Accounting	8.1yrs	sin datos	sin datos
Chih Cheng	Chief Information Security Officer	less than a year	sin datos	sin datos

0.7yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de 4129 no se considera experimentado ( 0.7 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Yan-Shen Lin	Chairman	31.7yrs	sin datos	3.02% NT$ 283.6m
Chun-Sheng Lin	Director	18.4yrs	sin datos	2.07% NT$ 194.6m
Hai-Yen Hau	Director	27.5yrs	sin datos	0.79% NT$ 74.5m
Ng Chor Wah	Director	19.4yrs	sin datos	1.73% NT$ 162.9m
Li-Ju Chen	Independent Director	no data	sin datos	sin datos
Te-Chien Lin	Director	4.4yrs	sin datos	sin datos
Chien-Lin Liu	Independent Director	4.4yrs	sin datos	sin datos
Kun-Chang Lee	Independent Director	4.4yrs	sin datos	sin datos
Meng-Ta Wu	Independent Director	4.4yrs	sin datos	sin datos

11.4yrs

Permanencia media

Junta con experiencia: Los miembros de la junta directiva de 4129 son experimentados ( 11.4 años antigüedad media).

United Orthopedic Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

United Orthopedic Corporation Announces Change in President

United Orthopedic Corporation Announces Establishment of Strategy Committee, Effective July 1, 2024

United Orthopedic Corporation, Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: NT$1.44 (vs NT$1.30 in 3Q 2023)

United Orthopedic Corporation to Report Q3, 2024 Results on Nov 05, 2024

Second quarter 2024 earnings released: EPS: NT$1.06 (vs NT$0.97 in 2Q 2023)

Now 26% overvalued

United Orthopedic Corporation to Report Q2, 2024 Results on Aug 09, 2024

Upcoming dividend of NT$4.00 per share

Dividend increased to NT$4.00

United Orthopedic Corporation Announces Change in President

United Orthopedic Corporation Announces Establishment of Strategy Committee, Effective July 1, 2024

First quarter 2024 earnings released: EPS: NT$0.98 (vs NT$0.85 in 1Q 2023)

United Orthopedic Corporation to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: NT$4.50 (vs NT$2.84 in FY 2022)

United Orthopedic Corporation, Annual General Meeting, Jun 18, 2024

Investor sentiment improves as stock rises 15%

New minor risk - Shareholder dilution

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Second quarter 2023 earnings released: EPS: NT$0.97 (vs NT$0.32 in 2Q 2022)

Upcoming dividend of NT$2.28 per share at 3.0% yield

Price target increased by 9.1% to NT$88.33

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: NT$2.84 (vs NT$0.37 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: NT$0.32 (vs NT$0.025 in 2Q 2021)

First quarter 2022 earnings released: EPS: NT$0.46 (vs NT$0.074 loss in 1Q 2021)

Price target decreased to NT$31.00

Less than half of directors are independent

Third quarter 2021 earnings released: EPS NT$0.05 (vs NT$0.49 in 3Q 2020)

Upcoming dividend of NT$0.84 per share

Second quarter 2021 earnings released: NT$0.04 loss per share (vs NT$0.063 profit in 2Q 2020)

First quarter 2021 earnings released: NT$0.07 loss per share (vs NT$0.17 loss in 1Q 2020)

Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

Full year 2020 earnings released: EPS NT$1.00 (vs NT$1.05 in FY 2019)

What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Is United Orthopedic (GTSM:4129) A Risky Investment?

Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

New 90-day low: NT$33.05

Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

New 90-day high: NT$36.05

How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: NT$35.60

Third quarter 2020 earnings released: EPS NT$0.49

New 90-day low - NT$33.05

First half earnings released

Upcoming Dividend of NT$0.82 Per Share

CEO

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media